- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Ertugliflozin; ertugliflozin with metformin – July 2018
Ertugliflozin: Tablet containing 15 mg ertugliflozin; Steglatro®; Ertugliflozin with metformin: Tabl
Last updated
26 October 2018